Prophylactic antibiotics to prevent surgical site infection after breast cancer surgery

Cochrane Database of Systematic Reviews

Volumn 2019, Issue 9, 2019, Pages

  Gallagher, Michael ^a   Jones, Daniel J ^b   Bell Syer, Sophie V ^c  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF HULL   (United Kingdom)

^c Bristol Medical School   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFAZOLIN; CEFONICID; CLARITHROMYCIN; COLLAGEN DERIVATIVE; DICLOXACILLIN; FLUCLOXACILLIN; GENTAMICIN; PLACEBO; SULTAMICILLIN;

ANTIBIOTIC PROPHYLAXIS; BREAST CANCER; BREAST RECONSTRUCTION; CANCER SURGERY; CLINICAL EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; FOLLOW UP; GASTROINTESTINAL DISEASE; HOSPITAL READMISSION; HUMAN; INCIDENCE; INFECTION PREVENTION; INFECTION RISK; NEOADJUVANT CHEMOTHERAPY; OUTCOME ASSESSMENT; POSTOPERATIVE CARE; PREOPERATIVE CARE; PRIORITY JOURNAL; RASH; REVIEW; RISK REDUCTION; SENSITIVITY ANALYSIS; SURGICAL INFECTION; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE; WOUND HEALING; BREAST TUMOR; FEMALE; MASTECTOMY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ANTIBIOTIC PROPHYLAXIS; BREAST NEOPLASMS; FEMALE; HUMANS; MASTECTOMY; PREOPERATIVE CARE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURGICAL WOUND INFECTION; WOUND HEALING;

EID: 85072790665     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD005360.pub5     Document Type: Review

References (83)

1. Amland PF, Andenaes K, Samdal F, Linaas E, Sandsmark M, Abeyholm F, et al. A prospective double-blind, placebo-controlled trial of a single dose of azithromycin on postoperative wound infections in plastic surgery. Plastic and Reconstructive Surgery 1995;96(6):1378-83.
2. Bold RJ, Mansfield PF, Berger DH, Pollock RE, Sinletary SE, Ames FC, et al. Prospective randomised, double-blind study of prophylactic antibiotics in axillary lymph node dissection. American Journal of Surgery 1998;176(3):239-43.
3. Cabaluna ND, Galicia RM, Yray MD. A randomized, double-blinded placebo-controlled clinical trial of the routine use of preoperative antibiotic prophylaxis in modified radical mastectomy. World Journal of Surgery 2012;37:59-66.
4. Chow LW, Yuen KY, Woo PC, Wei W. Clarithromycin attenuates mastectomy-induced acute inflammatory response. Clinical and Diagnostic Laboratory Immunology 2000;7(6):925-31.
5. Gulluoglu B, Guler S, Ugurlu U. Efficacy of prophylactic antibiotic administration for breast cancer surgery in overweight or obese patients. Annals of Surgery 2013;257(1):37-43.
6. Gupta R, Sinnett D, Carpenter R, Preece PE, Royle GT. Antibiotic prophylaxis for post-operative wound infection in clean elective breast surgery. European Journal of Surgical Oncology 2000;26(4):363-6.
7. Hall JC, Willsher PC, Hall JL. Randomized clinical trial of single-dose antibiotic prophylaxis for non-reconstructive breast surgery. British Journal of Surgery 2006;93(11):1342-6.
8. Paajanen H, Hermunen H. Does preoperative core needle biopsy increase surgical site infections in breast cancer surgery? Randomized study of antibiotic prophylaxis. Surgical Infections 2009;10(4):317-21.
9. Platt R, Zaleznik DF, Hopkins CC, Dellinger EP, Karchmer AW, Bryan CS, et al. Perioperative antibiotic prophylaxis for hernioplasty and breast surgery. New England Journal of Medicine 1990;322(3):153-60.
10. Wagman LD, Tegtmeier B, Beatty JD, Kloth DD, Kokal WA, Riihimaki DU, et al. A prospective, randomised double-blind study of the use of antibiotics at the time of mastectomy. Surgery, Gynecology & Obstetrics 1990;170(1):12-6.
11. Yetim I, Ozkan OV, Dervisoglu A, Erzurumlu K, Canbolant E. Effect of local gentamycin application on healing and wound infection in patients with modified radical mastectomy: a prospective randomised study. Journal of International Medical Research 2010;38(4):1442-7.
12. Baker KA. Antibiotic prophylaxis for selected implants and devices. CDA Journal California Dental Association 2000;28(35):620-6.
13. Bertin ML, Crowe J, Gordan S. Determinants of surgical site infection after breast surgery. American Journal of Infection Control 1998;26(1):61-5.
14. Boyd R, Burkhardt MD, Fried M, Schnur PL, Todfield JJ. Capsules, infections and intraluminal antibiotics. Plastic and Reconstructive Surgery 1981;68(1):43-7.
15. D'Amico DF, Parimbelli P, Ruffolo C. Antibiotic prophylaxis in clean surgery: breast surgery and hernia repair. Journal of Chemotherapy 2001;13(1):108-11.
16. Erfle V, Schoen A, Marquart KH, Pawlita M. Vaccine against cancer infection prevention and cancer prevention: final report on the joint project 01SF98 HGF Infection Defence and Cancer Prevention Strategy Fund [HGF-Strategiefond 'Infektabwehr und Krebspraevention'. Impfstoff gegen krebs-Infektionsabwehr und Krebspraevention. Abschlussbericht. GSF-Forschungszentrum fuer Umwelt und Gesundhiet Neuherberg GmbH Oberschleissheim (DE)]. SIGLE 2002.
17. Esposito S, Leone S, Noviello S, Ianniello F, Marvaso A, Cuniato V, et al. Antibiotic prophylaxis in hernia repair and breast surgery: a prospective randomised study comparing piperacillin/tazobactam versus placebo. Journal of Chemotherapy 2006;18(3):278-84.
18. Franchelli S, Leone MS, Vigna E, Rapsosio E, Cafierio F, Constantini M, et al. Perioperative teicoplanin prophylaxis in patients undergoing breast reconstruction with the abdominal wall. A case control study. Minerva Chirurgica 1994;49(1):59-60.
19. Hall JC, Hall JL. Antibiotic prophylaxis for patients undergoing breast surgery. Journal of Hospital Infection 2000;46(3):165-70.
20. LeRoy J, Given KS. Wound infection in breast augmentation: the role of prophylactic perioperative antibiotics. Aesthetic Plastic Surgery 1991;15(4):303-5.
21. Lewin R, Elander A, Thorarinsson A, Kolby L, Sahlin P, Lundberg J, et al. A randomized prospective study of prophylactic cloxacillin in breast reduction surgery. Annals of Plastic Surgery 2015;74(1):17-21.
22. Lewis RT, Weigand FM, Mamazza J, Lloyd-Smith W, Tataryn D. Should antibiotic prophylaxis be used routinely in clean surgical procedures: a tentative yes. Surgery 1995;118(4):742-7.
23. Morimoto K, Kinoshita H. Once daily use of ofloxacin for prophylaxis in breast cancer surgery. Chemotherapy 1998;44(2):135-41.
24. Penel N, Fournier C, Giard S, Lefebvres D. A prospective evaluation of antibiotic prophylaxis for breast surgery following previous chemotherapy. Bulletin du Cancer 2004;91(5):445-8.
25. Penel N, Yazdanpanah Y, Chauvet MP, Clisant S, Giard S, Neu JC, et al. Prevention of surgical site infection after breast cancer surgery by targeted prophylaxis antibiotic in patients at high risk of surgical site infection. Journal of Surgical Oncology 2007;96(2):124-9.
26. Phillips BT, Fourman MS, Bishawi M, Zegers M, O'Hea B, Ganz JC, et al. Are prophylactic postoperative antibiotics necessary for immediate breast reconstruction? Results of a prospective randomized clinical trial. Journal of the American College of Surgeons 2016;222(6):1116-24.
27. Platt R, Zucker JR, Zaleznik DF, Hopkins CC, Dellinger EP, Karchmer AW, et al. Prophylaxis against wound infection following hernioplasty or breast surgery. Journal of Infectious Diseases 1992;166(3):556-60.
28. Platt R, Zucker JR, Zaleznik DF, Hopkins CC, Dellinger EP, Karchmer AW, et al. Perioperative antibiotic prophylaxis and wound infection following breast surgery. Journal of Antimicrobial Chemotherapy 1993;31(Suppl B):43-8.
29. Ruiz-Tovar J, Casado P, Perez-Soler M, Gomez MA, Llavero C, Calero P, et al. Effect of gentamicin lavage of the axillary surgical bed after lymph node dissection on drainage discharge volume. Breast 2013;22(5):874-8.
30. Sanguinetti A, Rosato L, Cirocchi R, Barberini F, Pezzolla A, Cavallaro G, et al. Antibiotic prophylaxis in breast surgery. Preliminary results of a multicenter randomised study on 1400 cases [Antibiotico profilassi in Chirurgia Senologica Risultati preliminari di uno studio multicentrico randomizzato su 1400 casi trattati]. Annali Italiani di Chirurgia 2009;80(4):275-9.
31. Sasaki F, Takada N, Hata Y, Kyunoh K, Uchino J. A study on the transfer of cefbuperazone into postoperative exudate in patients subjected to cancer mastectomy or thyroidectomy. Japanese Journal of Antibiotics 1988;466:114-20.
32. Serletti JM, Davenport MS, Herrera HR, Caldwell EH. Efficacy of prophylactic antibiotics in reduction mammoplasty. Annals of Plastic Surgery 1994;33(5):476-80.
33. Shamilov AK, Smolianskaia AZ. The antibiotic prophylaxis of postoperative complications in breast cancer patients. Antibiotiki i Khimioterapiia 1991;36(6):43-4.
34. Spicher I, Beer GM, Minder J, Ruef Ch, Szucs T, Meyer VE. Perioperative antibiotic prophylaxis at the clinic of reconstructive surgery of the university hospital Zurich [Zur umsetzung einer perioperativen antibiotikapropylaxe an der klinik fur wiederstellungschirugie des universitatsspitals Zurich]. Swiss Surgery 2003;9(1):9-14.
35. Sultan S, Ahmed R, Mufti T, Mohammad G, Nawaz M. Use of prophylactic antibiotics in clean surgical cases-a prospective trial of various regimens. Journal of Pakistan Medical Association 1989;39(1):9-12.
36. Thomas R, Alivino P, Cortino GR, Accardo R, Rinaldo M, Pizzorusso M, et al. Long acting versus short acting cephalosporins for preoperative prophylaxis in breast surgery: a randomised double-blind trial involving 1,766 patients. Chemotherapy 1999;45(3):217-23.
37. Yang S, Liu G, Tang D, Cai D. Evaluation intravenous drip cephazolin prophylaxis of breast cancer surgery site infection. Journal of Craniofacial Surgery 2017;28(6):e527-31.
38. Exner K, Lang E, Borsche A, Lemperle G. Efficacy, tolerability and pharmacokinetics of teicoplanin in patients undergoing breast surgery. European Journal of Surgery. Supplement 1992;567:9-12.
39. Kumar S, Melling A, Wong PF, Whetter D, Leaper DJ. Wound infection prophylaxis in breast surgery: a randomised controlled trial comparing the efficacy of antibiotics and perioperative wound warming. British Journal of Surgery 2005;92(1):67.
40. Prudencio RM, Campos F, Archangelo I, Juliano Y, Ferreira LM, Veiga DF. Antibiotic prophylaxis in breast cancer surgery-randomized clinical trial. Journal of Women's Health 2017;26(4):A15-6.
41. Ayeleke RO, Mourad S, Marjoribanks J, Calis KA, Jordan V. Antibiotic prophylaxis for elective hysterectomy. Cochrane Database of Systematic Reviews 2017, Issue 6. [DOI: 10.1002/14651858.CD004637.pub2]
42. Coello R, Glenister H, Fereres J, Bartlett C, Leigh D, Sedgwick J, et al. The cost of infection in surgical patients: a case control study. Journal of Hospital Infection 1993;25(4):239-50.
43. Davies SC. Annual Report of the Chief Medical Officer, Volume Two, 2011, Infections and the rise of antimicrobial resistance. London: Department of Health. 2013. www.gov.uk/government/ publications/chief-medical-officer-annual-report-volume-2 (accessed 1 October 2018).
44. Donegan WL, Spratt JS. Cancer of the Breast. Missouri: Elsevier Science, 1995.
45. Global Cancer Observatory (GCO). Cancer Today. 2018. gco.iarc.fr/today/home (accessed 1 October 2018).
46. Gillespie WJ, Walenkamp G. Antibiotic prophylaxis for surgery for proximal femoral and other closed long bone fractures. Cochrane Database of Systematic Reviews 2010, Issue 3. [DOI: 10.1002/14651858.CD000244.pub2]
47. Schünemann H, Brożek J, Guyatt G, Oxman A, editor(s). Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013. Available from gdt.guidelinedevelopment.org/app/handbook/handbook.html.
48. Evidence Prime, Inc. GDT: GRADEpro Guideline Development Tool. Evidence Prime, Inc., 2015.
49. Gruendemann BJ, Magnum SS. Infection prevention in the surgical setting. London: WB Saunders, 2001.
50. Haley RW, Culver DH, Mead Morgan W, White JW, Emori GT, Hooton TM. Identifying patients at high risk of surgical wound infection. American Journal of Epidemiology 1985;121(2):206-15.
51. Harris JR, editor(s). Diseases of the Breast. Philadelphia: Lippincott Williams & Wilkins, 2004.
52. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-60.
53. Higgins JP, Altman DG, editor(s), on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group. Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
54. Hróbjartsson A, Gøtzsche PC. Placebo interventions for all clinical conditions. Cochrane Database of Systematic Reviews 2010, Issue 1. [DOI: 10.1002/14651858.CD003974.pub3]
55. Lefebvre D, Penel N, Deberles MF, Fournier C. Incidence and surgical wound infection risk factors in breast cancer surgery. Presse Medicale 2000;29(35):1927-32.
56. Lefebvre C, Manheimer E, Glanville J, on behalf of the Cochrane Information Retrieval Methods Group. Chapter 6: Searching for studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
57. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLOS Medicine 2009;6(7):e1000100.
58. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for the prevention of surgical site infection. Infection Control and Hospital Epidemiology 1999;20(4):247-78.
59. Mitchell DH, Swift G, Gilberts GL. Surgical wound infection surveillance: the importance of infections that develop after hospital discharge. ANZ Journal of Surgery 1999;69(2):117-20.
60. Morris DM, Robinson K. The effect of method of biopsy and timing of mastectomy on the development of post mastectomy non sociocomial wound infection. Journal of the Louisiana State Medical Society 1988;140(37):363-6.
61. National Institute for Health and Care Excellence (NICE). Improving outcomes in breast cancer. Cancer service guideline [CSG1]. Published August 2002. www.nice.org.uk/guidance/csg1 (accessed 8 May 2018).
62. Pittet B, Montandon D, Pittet D. Infection in breast implants. Lancet Infectious Diseases 2005;5(2):94-106.
63. Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
64. Ritter MA, Marmion P. The exogenous sources and controls of microorganisms in the operating room. Orthopaedic Nursing 1988;7(4):23-8.
65. Sajid MS, Hutson K, Akhter N, Kalra L, Rapisarda IF, Bonomi R. An updated meta-analysis on the effectiveness of preoperative prophylactic antibiotics in patients undergoing breast surgical procedures. Breast Journal 2012;18(4):312-7.
66. Sanchez-Manuel FJ, Lozano-García J, Seco-Gil JL. Antibiotic prophylaxis for hernia repair. Cochrane Database of Systematic Reviews 2012, Issue 2. [DOI: 10.1002/14651858.CD003769.pub3]
67. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273(5):408-12.
68. Schünemann HJ, Oxman AD, Visit GE, Higgins JP, Deeks JJ, Glasziou P, et al. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
69. Schünemann HJ, Oxman AD, Higgins JP, Vist GE, Glasziou P, Guyatt GH. Chapter 11: Presenting results and ’Summary of findings’ tables. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
70. Sheridan RL, Tompkins RG, Burke JF. Prophylactic antibiotics and their role in the prevention of surgical wound infection. Advances in Surgery 1994;27:43-65.
71. Shortt R, Cooper MJ, Farrokhyar F, Bain J. Meta-analysis of antibiotic prophylaxis in breast reduction surgery. Plastic Surgery 2014;22(2):91-4.
72. Scottish Intercollegiate Guidelines Network (SIGN). Antibiotic prophylaxis in surgery: a national clinical guideline. SIGN 104. July 2008, updated April 2014. www.sign.ac.uk/assets/ sign104.pdf (accessed 8 May 2018).
73. Scottish Intercollegiate Guidelines Network (SIGN). Search filters. www.sign.ac.uk/search-filters.html (accessed 8 May 2018).
74. Spauwen PH, Wobbes T, Van Der Sluis RF. Immediate breast reconstruction: results and satisfaction. European Journal of Plastic Surgery 2000;23:211-3.
75. Tejirian T, DiFronzo A, Haigh PI. Antibiotic prophylaxis for preventing wound infection after breast surgery: a systematic review and meta analysis. Journal of the American College of Surgeons 2006;203(5):729-34.
76. Tran CL, Langer S, Brodwick-Villa G, DiFronzo LA. Does re-operation predispose to post-operative wound infection in women undergoing operation for breast cancer?. American Surgery 2003;69(10):852-6.
77. Vazquez-Aragon P, Lizan-Garcia M, Cascales-Sanchez P, Villar-Canovas MT, Garcia-Olmo D. Nosocomial infection and related risk factors in a general surgery setting: a prospective study. Journal of Infection 2003;46(1):17-22.
78. Wilson AP, Treasure T, Sturridge MF, Gruneberg RN. A scoring method (ASEPSIS) for postoperative wound infections for use in clinical trials of antibiotic prophylaxis. Lancet 1986;1(8476):311-3.
79. Witt A, Yavuz D, Walchetseder C, Strohmer H, Kubista E. Preoperative core needle biopsy as an independent risk factor for wound infection after breast surgery. Obstetrics and Gynecology 2003;101(4):745-50.
80. Bunn F, Jones DJ, Bell-Syer S. Prophylactic antibiotics to prevent surgical site infection after breast cancer surgery. Cochrane Database of Systematic Reviews 2012, Issue 1. [DOI: 10.1002/14651858.CD005360.pub3]
81. Cunningham ME, Bunn F, Handscomb K. Prophylactic antibiotics to prevent surgical site infection after breast cancer surgery. Cochrane Database of Systematic Reviews 2005, Issue 3. [DOI: 10.1002/14651858.CD005360]
82. Cunningham ME, Bunn F, Handscomb K. Prophylactic antibiotics to prevent surgical site infection after breast cancer surgery. Cochrane Database of Systematic Reviews 2005, Issue 1. [DOI: 10.1002/14651858.CD005360]
83. Jones DJ, Bunn F, Bell-Syer SV. Prophylactic antibiotics to prevent surgical site infection after breast cancer surgery. Cochrane Database of Systematic Reviews 2014, Issue 3. [DOI: 10.1002/14651858.CD005360.pub4]